To Evaluate Eye Installation-Tear Free
NCT02802917 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83
Last updated 2018-12-12
Summary
The primary objective of this study was to compare the human eye stinging potential of experimental formulas of sun care products \[Sun Protection Factor (SPF) 50 Y49 091, SPF 50 X15 158, SPF 50 X15 160 and SPF 50 X57 162 compared to an industry standard shampoo mixture.
Conditions
- Sunscreening Agents
Interventions
- DRUG
-
SPF 50 Y49 091 (BAY 987516)
5 μL of the appropriate test or control article were instilled into the lower conjunctival sac of the eye.
- DRUG
-
SPF 50 X15 158 (BAY 987516)
5 μL of the appropriate test or control article were instilled into the lower conjunctival sac of the eye.
- DRUG
-
SPF 50 X15 160 (BAY 987516)
5 μL of the appropriate test or control article were instilled into the lower conjunctival sac of the eye.
- DRUG
-
SPF 50 X57 162 (BAY 987516)
5 μL of the appropriate test or control article were instilled into the lower conjunctival sac of the eye.
- OTHER
-
J & J baby shampoo, X46 046 (control)
5 μL of the appropriate test or control article were instilled into the lower conjunctival sac of the eye.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-05-15
- Primary Completion
- 2015-05-24
- Completion
- 2015-05-24
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of the Irritation Potential of Products in Human Eyes
NCT02714166 ·Status: COMPLETED ·Phase: NA
-
Short-term Effects on Tear Film (Baby Shampoo vs Blephasol)
NCT04858113 ·Status: UNKNOWN ·Phase: NA
-
Systemic Pharmacokinetics of BOL-303224-A
NCT00407589 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Controlled Adverse Environment (CAE) on Tear Film Stability
NCT01547936 ·Status: COMPLETED
-
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
NCT00932477 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating Safety of BT01001 Ophthalmic Solution
NCT07313722 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion
NCT02338648 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
NCT05865379 ·Status: RECRUITING ·Phase: NA
-
Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease
NCT02831387 ·Status: TERMINATED ·Phase: PHASE2
-
Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
NCT05467293 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis
NCT01560962 ·Status: TERMINATED ·Phase: NA
-
Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye
NCT06860659 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
NCT00241319 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome
NCT03162783 ·Status: COMPLETED ·Phase: PHASE2
-
Blephacura Versus Baby Shampoo to Treat Blepharitis
NCT01115192 ·Status: COMPLETED ·Phase: NA
-
A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
NCT04734197 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye
NCT04633213 ·Status: COMPLETED ·Phase: PHASE3
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
NCT00622037 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03846453 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
NCT04041856 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment of Severe Ocular Chemical Burns by Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells: An Open-Label, Single-Arm, Multicenter Phase II Trial
NCT07329569 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Lid Wipes Versus Baby Shampoo in Patients With Seborrehic Blepharitis
NCT04441528 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure
NCT06080438 ·Status: TERMINATED ·Phase: PHASE4
-
EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)
NCT05127525 ·Status: TERMINATED ·Phase: PHASE3